About Marathon Pharma
Marathon Pharma is a Healthcare company based in Northbrook (United States) founded in 2012. New treatments for rare neurological and movement disorders are developed. The company has 3 employees. Its focus areas include Life Sciences, Rare Diseases, Drugs and Diversified. Similar companies include Moderna, BridgeBio and Spark Therapeutics; 3 of its 3 listed similar companies have raised funding.
Company details
Marathon Pharmaceuticals was founded in 2012 and is headquartered in Northbrook, United States. Operations center on the biopharmaceutical sector, with treatments developed for rare neurological and movement disorders. Deflazacort for Duchenne Muscular Dystrophy has completed Phase 3 and reached Pre-NDA. Additional candidates are advanced for polyarticular juvenile idiopathic arthritis in Phase 3, neuromyelitis optica in Phase 2, idiopathic inflammatory myopathies in Phase 1, and catastrophic pediatric epilepsy in Phase 1.
- Headquarters Northbrook, United States
- Employees 3
- SectorsHealthcare
- Email••••••••
- Website marathonpharma.com
- Social LinkedIn
- Employee Count3
Similar companies to Marathon Pharma
Marathon Pharma has 3 listed similar companies in our database, 3 of them funded. They include Moderna, BridgeBio and Spark Therapeutics.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| modernatx.com | 2010 | Cambridge, United States | $2.78B | 1,312 | mRNA-based therapeutics for diseases including cancer and infections are developed. | |
| bridgebio.com | 2015 | Palo Alto, United States | $434.2M | Therapeutics for genetic diseases are developed through targeted interventions. | ||
| sparktx.com | 2013 | Philadelphia, United States | $82.8M | 822 | Gene therapies for rare diseases including retinal dystrophies are developed. |
Detailed similar companies of Marathon Pharma
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Marathon Pharma
Websites that share an audience with Marathon Pharma (marathonpharma.com).
Websites whose visitors overlap most with Marathon Pharma. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
alxn.com | alxn.com | 100% | – | ||
alexionpharma.com | alexionpharma.com | 100% | – | ||
| hapco.co.in | 76% | 1.9K | #8,963,073 | View details | |
| raredis.org | 62% | 8.1K | #2,990,876 | View details | |
| eurordis.org | 62% | 56.8K | #660,296 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 10 similar websites and full traffic analytics for Marathon Pharma
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 10 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Rare Diseases
3 companies that operate in the same segment as Marathon Pharma (Rare Diseases) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Gene therapies for rare diseases including retinal dystrophies are developed. | 2013 | Philadelphia, Pennsylvania, United States | USD 82.8 M | USD 64.73 M | 822 | |
Therapeutics for genetic diseases are developed through targeted interventions. | 2015 | Palo Alto, California, United States | USD 434.2 M | USD 502.08 M | 730 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Marathon Pharma
Complete news archive for Marathon Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Marathon Pharma
Marathon Pharma was founded in 2012.
Marathon Pharma is headquartered in Northbrook, United States. It is registered at Northbrook, Illinois, United States.
Marathon Pharma has 3 employees.
Marathon Pharmaceuticals was founded in 2012 and is headquartered in Northbrook, United States. Operations center on the biopharmaceutical sector, with treatments developed for rare neurological and movement disorders. Deflazacort for Duchenne Muscular Dystrophy has completed Phase 3 and reached Pre-NDA. Additional candidates are advanced for polyarticular juvenile idiopathic arthritis in Phase 3, neuromyelitis optica in Phase 2, idiopathic inflammatory myopathies in Phase 1, and catastrophic pediatric epilepsy in Phase 1.
Marathon Pharma's top competitors include Moderna, Spark Therapeutics and BridgeBio.